Fig. 2From: Imaging modalities in differential diagnosis of Parkinson’s disease: opportunities and challengesThe administration of 18FDG-PET for the diagnosis of Parkinson’s and degenerative parkinsonism disorders. Consequences of the between-group statistical parametric mapping analysis for each diagnostic category shown in the vertical axis as follows: Parkinson’s disease (PD), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD), vs. healthy controls. The red and yellow colors highlighted regions superimposed on normal T1-weighted MR templates showing areas with significantly reduced FDG uptake relative to the global mean [78]Back to article page